Humacyte Inc. Company Profile
NASDAQ: HUMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.4723-0.0057 (-1.19%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Humacyte at a glance
Humacyte Inc. (NASDAQ: HUMA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2020. At a market capitalization of $132.8 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001818382, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Humacyte Inc.
- Ticker
- NASDAQ: HUMA
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2020
- Market cap
- $132.79M
- SEC CIK
- 0001818382
Companies similar to Humacyte
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ARMPArmata Pharmaceuticals Inc. | 3.81 | -1.04% | $141.66M | vs HUMA |
| AVXLAnavex Life Sciences Corp. | 1.53 | -4.38% | $141.83M | vs HUMA |
| OTLKOutlook Therapeutics Inc. | 0.59 | +3.15% | $143.63M | vs HUMA |
| MOLNMolecular Partners AG ADR | 3.81 | +0.79% | $145.94M | vs HUMA |
| TNYATenaya Therapeutics Inc. | 0.5334 | -2.40% | $119.60M | vs HUMA |
| ENGNenGene Therapeutics Inc. | 1.75 | -3.06% | $116.94M | vs HUMA |
| LENZLENZ Therapeutics Inc. | 3.62 | -4.49% | $113.74M | vs HUMA |
| ABOSAcumen Pharmaceuticals Inc. | 2.10 | +3.45% | $151.87M | vs HUMA |